A Methylazanediyl Bisacetamide Derivative Sensitizes Staphylococcus aureus Persisters to a Combination of Gentamicin And Daptomycin

Abstract Infections caused by Staphylococcus aureus, notably methicillin‐resistant S. aureus (MRSA), pose treatment challenges due to its ability to tolerate antibiotics and develop antibiotic resistance. The former, a mechanism independent of genetic changes, allows bacteria to withstand antibiotic...

Full description

Bibliographic Details
Main Authors: Hee Young Heo, Guijin Zou, Seongeun Baek, Jae‐Seok Kim, Eleftherios Mylonakis, Frederick M. Ausubel, Huajian Gao, Wooseong Kim
Format: Article
Language:English
Published: Wiley 2024-03-01
Series:Advanced Science
Subjects:
Online Access:https://doi.org/10.1002/advs.202306112
_version_ 1827325081592791040
author Hee Young Heo
Guijin Zou
Seongeun Baek
Jae‐Seok Kim
Eleftherios Mylonakis
Frederick M. Ausubel
Huajian Gao
Wooseong Kim
author_facet Hee Young Heo
Guijin Zou
Seongeun Baek
Jae‐Seok Kim
Eleftherios Mylonakis
Frederick M. Ausubel
Huajian Gao
Wooseong Kim
author_sort Hee Young Heo
collection DOAJ
description Abstract Infections caused by Staphylococcus aureus, notably methicillin‐resistant S. aureus (MRSA), pose treatment challenges due to its ability to tolerate antibiotics and develop antibiotic resistance. The former, a mechanism independent of genetic changes, allows bacteria to withstand antibiotics by altering metabolic processes. Here, a potent methylazanediyl bisacetamide derivative, MB6, is described, which selectively targets MRSA membranes over mammalian membranes without observable resistance development. Although MB6 is effective against growing MRSA cells, its antimicrobial activity against MRSA persisters is limited. Nevertheless, MB6 significantly potentiates the bactericidal activity of gentamicin against MRSA persisters by facilitating gentamicin uptake. In addition, MB6 in combination with daptomycin exhibits enhanced anti‐persister activity through mutual reinforcement of their membrane‐disrupting activities. Crucially, the “triple” combination of MB6, gentamicin, and daptomycin exhibits a marked enhancement in the killing of MRSA persisters compared to individual components or any double combinations. These findings underscore the potential of MB6 to function as a potent and selective membrane‐active antimicrobial adjuvant to enhance the efficacy of existing antibiotics against persister cells. The molecular mechanisms of MB6 elucidated in this study provide valuable insights for designing anti‐persister adjuvants and for developing new antimicrobial combination strategies to overcome the current limitations of antibiotic treatments.
first_indexed 2024-03-07T14:14:10Z
format Article
id doaj.art-f853eeb6525745e880a60d08b482582a
institution Directory Open Access Journal
issn 2198-3844
language English
last_indexed 2024-03-07T14:14:10Z
publishDate 2024-03-01
publisher Wiley
record_format Article
series Advanced Science
spelling doaj.art-f853eeb6525745e880a60d08b482582a2024-03-06T14:04:50ZengWileyAdvanced Science2198-38442024-03-01119n/an/a10.1002/advs.202306112A Methylazanediyl Bisacetamide Derivative Sensitizes Staphylococcus aureus Persisters to a Combination of Gentamicin And DaptomycinHee Young Heo0Guijin Zou1Seongeun Baek2Jae‐Seok Kim3Eleftherios Mylonakis4Frederick M. Ausubel5Huajian Gao6Wooseong Kim7College of Pharmacy Graduate School of Pharmaceutical Sciences Ewha Womans University Seoul 03760 Republic of KoreaInstitute of High Performance Computing (IHPC) Agency for Science Technology and Research (A*STAR) Singapore 138632 Republic of SingaporeCollege of Pharmacy Graduate School of Pharmaceutical Sciences Ewha Womans University Seoul 03760 Republic of KoreaDepartment of Laboratory Medicine Kangdong Sacred Heart Hospital Hallym University College of Medicine Seoul 05355 Republic of KoreaDepartment of Medicine Houston Methodist Hospital Houston TX 77030 USADepartment of Molecular Biology Massachusetts General Hospital Boston MA 02114 USAInstitute of High Performance Computing (IHPC) Agency for Science Technology and Research (A*STAR) Singapore 138632 Republic of SingaporeCollege of Pharmacy Graduate School of Pharmaceutical Sciences Ewha Womans University Seoul 03760 Republic of KoreaAbstract Infections caused by Staphylococcus aureus, notably methicillin‐resistant S. aureus (MRSA), pose treatment challenges due to its ability to tolerate antibiotics and develop antibiotic resistance. The former, a mechanism independent of genetic changes, allows bacteria to withstand antibiotics by altering metabolic processes. Here, a potent methylazanediyl bisacetamide derivative, MB6, is described, which selectively targets MRSA membranes over mammalian membranes without observable resistance development. Although MB6 is effective against growing MRSA cells, its antimicrobial activity against MRSA persisters is limited. Nevertheless, MB6 significantly potentiates the bactericidal activity of gentamicin against MRSA persisters by facilitating gentamicin uptake. In addition, MB6 in combination with daptomycin exhibits enhanced anti‐persister activity through mutual reinforcement of their membrane‐disrupting activities. Crucially, the “triple” combination of MB6, gentamicin, and daptomycin exhibits a marked enhancement in the killing of MRSA persisters compared to individual components or any double combinations. These findings underscore the potential of MB6 to function as a potent and selective membrane‐active antimicrobial adjuvant to enhance the efficacy of existing antibiotics against persister cells. The molecular mechanisms of MB6 elucidated in this study provide valuable insights for designing anti‐persister adjuvants and for developing new antimicrobial combination strategies to overcome the current limitations of antibiotic treatments.https://doi.org/10.1002/advs.202306112antibiotic resistanceantibiotic toleranceCaenorhabditis elegansmembrane‐active antimicrobialsmethylazanediyl bisacetamideMRSA
spellingShingle Hee Young Heo
Guijin Zou
Seongeun Baek
Jae‐Seok Kim
Eleftherios Mylonakis
Frederick M. Ausubel
Huajian Gao
Wooseong Kim
A Methylazanediyl Bisacetamide Derivative Sensitizes Staphylococcus aureus Persisters to a Combination of Gentamicin And Daptomycin
Advanced Science
antibiotic resistance
antibiotic tolerance
Caenorhabditis elegans
membrane‐active antimicrobials
methylazanediyl bisacetamide
MRSA
title A Methylazanediyl Bisacetamide Derivative Sensitizes Staphylococcus aureus Persisters to a Combination of Gentamicin And Daptomycin
title_full A Methylazanediyl Bisacetamide Derivative Sensitizes Staphylococcus aureus Persisters to a Combination of Gentamicin And Daptomycin
title_fullStr A Methylazanediyl Bisacetamide Derivative Sensitizes Staphylococcus aureus Persisters to a Combination of Gentamicin And Daptomycin
title_full_unstemmed A Methylazanediyl Bisacetamide Derivative Sensitizes Staphylococcus aureus Persisters to a Combination of Gentamicin And Daptomycin
title_short A Methylazanediyl Bisacetamide Derivative Sensitizes Staphylococcus aureus Persisters to a Combination of Gentamicin And Daptomycin
title_sort methylazanediyl bisacetamide derivative sensitizes staphylococcus aureus persisters to a combination of gentamicin and daptomycin
topic antibiotic resistance
antibiotic tolerance
Caenorhabditis elegans
membrane‐active antimicrobials
methylazanediyl bisacetamide
MRSA
url https://doi.org/10.1002/advs.202306112
work_keys_str_mv AT heeyoungheo amethylazanediylbisacetamidederivativesensitizesstaphylococcusaureuspersisterstoacombinationofgentamicinanddaptomycin
AT guijinzou amethylazanediylbisacetamidederivativesensitizesstaphylococcusaureuspersisterstoacombinationofgentamicinanddaptomycin
AT seongeunbaek amethylazanediylbisacetamidederivativesensitizesstaphylococcusaureuspersisterstoacombinationofgentamicinanddaptomycin
AT jaeseokkim amethylazanediylbisacetamidederivativesensitizesstaphylococcusaureuspersisterstoacombinationofgentamicinanddaptomycin
AT eleftheriosmylonakis amethylazanediylbisacetamidederivativesensitizesstaphylococcusaureuspersisterstoacombinationofgentamicinanddaptomycin
AT frederickmausubel amethylazanediylbisacetamidederivativesensitizesstaphylococcusaureuspersisterstoacombinationofgentamicinanddaptomycin
AT huajiangao amethylazanediylbisacetamidederivativesensitizesstaphylococcusaureuspersisterstoacombinationofgentamicinanddaptomycin
AT wooseongkim amethylazanediylbisacetamidederivativesensitizesstaphylococcusaureuspersisterstoacombinationofgentamicinanddaptomycin
AT heeyoungheo methylazanediylbisacetamidederivativesensitizesstaphylococcusaureuspersisterstoacombinationofgentamicinanddaptomycin
AT guijinzou methylazanediylbisacetamidederivativesensitizesstaphylococcusaureuspersisterstoacombinationofgentamicinanddaptomycin
AT seongeunbaek methylazanediylbisacetamidederivativesensitizesstaphylococcusaureuspersisterstoacombinationofgentamicinanddaptomycin
AT jaeseokkim methylazanediylbisacetamidederivativesensitizesstaphylococcusaureuspersisterstoacombinationofgentamicinanddaptomycin
AT eleftheriosmylonakis methylazanediylbisacetamidederivativesensitizesstaphylococcusaureuspersisterstoacombinationofgentamicinanddaptomycin
AT frederickmausubel methylazanediylbisacetamidederivativesensitizesstaphylococcusaureuspersisterstoacombinationofgentamicinanddaptomycin
AT huajiangao methylazanediylbisacetamidederivativesensitizesstaphylococcusaureuspersisterstoacombinationofgentamicinanddaptomycin
AT wooseongkim methylazanediylbisacetamidederivativesensitizesstaphylococcusaureuspersisterstoacombinationofgentamicinanddaptomycin